Literature DB >> 12922958

Perturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus.

M Odendahl1, R Keitzer, U Wahn, F Hiepe, A Radbruch, T Dörner, R Bunikowski.   

Abstract

OBJECTIVE: To investigate the distribution of peripheral B cell subpopulations of children with active and inactive systemic lupus erythematosus (SLE) compared with healthy controls.
METHODS: Peripheral B cell subpopulations of 11 children with SLE (6 with active and 5 with inactive disease) and 14 age matched normal healthy children were analysed. Active disease was diagnosed in children with a flare of SLE, who received treatment by i.v. cyclophosphamide or i.v. methylprednisolone pulse to control the disease. Additionally, the peripheral B cells of the children with SLE were compared with those of 13 consecutive patients with adult onset SLE.
RESULTS: No major difference was found in the frequency and total number of CD27(-)/CD19(+) naïve B cells and CD27(+)/CD19(+) memory B cells between patients with active and inactive lupus and healthy controls, but there was a significant increase in CD27(high) expressing plasma blasts in patients with active SLE. These cells coexpress CD38(+), HLA-DR(dim), surface Ig(low) and lack the expression of CD20 but are clearly positive for intracellular Ig, indicative of early plasma cells. Most CD138(+) cells coexpress CD27(high)/CD19(+). The enhanced frequency of peripheral plasma blasts in children with active SLE is consistent with previous findings in adult patients with SLE, whereas a relative predominance of CD27(+) memory B cells was only identified in the adult patients.
CONCLUSIONS: Profound abnormalities in the distribution of B cell compartments are more pronounced in older patients with SLE, but an enhanced frequency and cell number of peripheral plasma blasts is characteristic of both diseases during active stages. Thus detection of CD27(high) plasma blasts significantly correlates with active lupus in both children and adults.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12922958      PMCID: PMC1754662          DOI: 10.1136/ard.62.9.851

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

Review 1.  Maturation and dispersal of B-cell clones during T cell-dependent antibody responses.

Authors:  I C MacLennan; Y J Liu; G D Johnson
Journal:  Immunol Rev       Date:  1992-04       Impact factor: 12.988

Review 2.  The central and multiple roles of B cells in lupus pathogenesis.

Authors:  O T Chan; M P Madaio; M J Shlomchik
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

3.  CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells.

Authors:  H Nagumo; K Agematsu; K Shinozaki; S Hokibara; S Ito; M Takamoto; T Nikaido; K Yasui; Y Uehara; A Yachie; A Komiyama
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

4.  Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity.

Authors:  M S Mahmoud; R Fujii; H Ishikawa; M M Kawano
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

5.  Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus.

Authors:  E Arce; D G Jackson; M A Gill; L B Bennett; J Banchereau; V Pascual
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

Review 6.  Management of systemic lupus erythematosus (SLE).

Authors:  S J Morton; R J Powell
Journal:  Clin Exp Allergy       Date:  2001-05       Impact factor: 5.018

7.  Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.

Authors:  M Odendahl; A Jacobi; A Hansen; E Feist; F Hiepe; G R Burmester; P E Lipsky; A Radbruch; T Dörner
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

9.  Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.

Authors:  W W Ginsburg; F D Finkelman; P E Lipsky
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

10.  Identification of functional human splenic memory B cells by expression of CD148 and CD27.

Authors:  S G Tangye; Y J Liu; G Aversa; J H Phillips; J E de Vries
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

View more
  26 in total

Review 1.  T cells that promote B-Cell maturation in systemic autoimmunity.

Authors:  Jason S Weinstein; Sairy G Hernandez; Joe Craft
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

2.  Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells.

Authors:  Ming You; Guanjun Dong; Fanlin Li; Feiya Ma; Jing Ren; Yujun Xu; Huimin Yue; Ruijing Tang; Deshan Ren; Yayi Hou
Journal:  Cell Mol Immunol       Date:  2015-08-17       Impact factor: 11.530

Review 3.  [Autoantibodies and antibody-secreting cells].

Authors:  F Hiepe; T Dörner
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

4.  Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  Jérémie Sellam; Corinne Miceli-Richard; Jacques-Eric Gottenberg; Marc Ittah; Frédéric Lavie; Christine Lacabaratz; Nicolas Gestermann; Alexis Proust; Olivier Lambotte; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2006-12-21       Impact factor: 19.103

Review 5.  Aberrant B-cell homeostasis in chronic GVHD.

Authors:  Stefanie Sarantopoulos; Jerome Ritz
Journal:  Blood       Date:  2015-02-02       Impact factor: 22.113

Review 6.  Immunology of IgG4-related disease.

Authors:  E Della-Torre; M Lanzillotta; C Doglioni
Journal:  Clin Exp Immunol       Date:  2015-06-08       Impact factor: 4.330

Review 7.  Indications for use and safety of rituximab in childhood renal diseases.

Authors:  Kjell Tullus; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2012-09-21       Impact factor: 3.714

8.  Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.

Authors:  Zachary S Wallace; Hamid Mattoo; Mollie Carruthers; Vinay S Mahajan; Emanuel Della Torre; Hang Lee; Maria Kulikova; Vikram Deshpande; Shiv Pillai; John H Stone
Journal:  Ann Rheum Dis       Date:  2014-05-09       Impact factor: 19.103

9.  [B-cell targeted therapy for children and adolescents with rheumatic diseases].

Authors:  H Morbach; H J Girschick
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

10.  Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor.

Authors:  M Margarida Souto-Carneiro; Vijayabhanu Mahadevan; Kazuki Takada; Ruth Fritsch-Stork; Toshihiro Nanki; Margaret Brown; Thomas A Fleisher; Mildred Wilson; Raphaela Goldbach-Mansky; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2009-06-05       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.